<DOC>
	<DOCNO>NCT00929877</DOCNO>
	<brief_summary>Primary Objective : To compare single-dose efficacy ketoprofen lysinate lozenge ( 6.25 mg 12.5 mg ketoprofen base ) placebo , total pain relief sum 15 120 min ( TOTPAR15-120 ) first intake study drug . Secondary Objectives : To compare single-dose efficacy ketoprofen lysinate lozenge ( 6.25mg 12.5mg ) placebo first intake : - total pain relief sum 15 360min ( TOTPAR15-360 ) - change baseline global throat pain intensity assess 15 120min 15 360min . - change baseline throat soreness 15 120min 15 360min - change baseline swell throat 15 120min 15 360min To compare pain relief , global throat pain intensity , throat soreness swell throat even day 1 , 2 3 To evaluate safety ketoprofen lysinate lozenge ( 6.25mg 12.5mg ) placebo follow-up visit : Day 4 : - adverse event clinical examination Day 7 : - adverse event report ( followed clinical examination need )</brief_summary>
	<brief_title>KRYSTAL- KetopRofen lYsinate Sore ThroAt Lozenges</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Inclusion criterion : Patients sore throat associate URTI &gt; = 24 hour &lt; = 6 day ' duration , absence A.Streptococcus* , Evidence tonsillopharyngitis ( TPA score &gt; = 5 ) inclusion , With score throat soreness &gt; = 6 ( 010 ordinal scale ) , With perception swell throat &gt; = 60mm ( VAS ) , With global throat pain intensity pain swallow assess VAS &gt; = 60 mm . *Specific exploration Inclusion : The Score Mac Isaac perform investigator . Presence streptococcus assess throat swab test Patients positive swab test include . Exclusion criterion : Patients use local medication contain local oral anesthetic lozenge , spray , mouth rinse topical throat treatment within 2 hour study entry Patients positive throat swab test A.Streptococcus pharyngitis Patients use analgesic within 4 hour study entry Patients use longacting slow release analgesic within 12 hour study entry Patients use anti inflammatory treatment 812 hour study entry Patients use anti histaminic 812 hour study entry Patients pharyngeal paresthesia Patients pharyngeal mycosis Patients know history ketoprofen , aspirin NSAIDinduced bronchospasm Hypersensitivity ketoprofen excipients Any disease could compromise breathe bronchopneumonia asthma Evidence mouthbreathing uncomfortable cough Any chronic disease require long period antiinflammatory treatment Any chronic disease require long term use anticoagulant use anticoagulant antiplatelet agent one week study entry , Women know pregnant . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>